BTS-21802-21980
3 vaccinations
4 coded responses
32 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 300 / GA
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Moderna
- 2021-03-08
- 2021-03-09
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-12
Survey response — days 1–6 daily, dose 1MedDRA: Office visit — Feeling: Fair · Headache · Be unable to work, Get care from a doctor or other healthcare professionalFree text: NeurologistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-14
- 2021-03-15
-
2021-03-22
Survey response — day 14, dose 1MedDRA: Dizziness — Feeling: FairFree text: Light headedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
-
2021-04-05
Dose 2 — Moderna
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, DiarrheaAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-14
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-07-05
- 2021-10-04
-
2021-11-16
Dose 3 — Moderna
-
2021-11-16
Health check-in — day 0, dose 3Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-11-19
- 2021-11-20
- 2021-12-23
- 2022-02-15
- 2022-03-02
-
2022-05-19
Survey response — 6 months, dose 3MedDRA: Ectopic pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Ectopic pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-05-19
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-05-20
-
2022-11-16
Survey response — 12 months, dose 3MedDRA: Ectopic pregnancy, Nasopharyngitis, Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Ectopic pregnancy, sinus infection, coldMedDRA releases: 2024-11 · check-in free text available
-
2022-11-16
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2022-11-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-11-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-11-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Moderna | |
| 2 | 2021-04-05 | Moderna | |
| 3 | 2021-11-16 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-12 | Successful 2022-11-17 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-05-19 | Successful 2022-11-17 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-11-16 | Successful 2022-11-17 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 5 — days 1–6 daily, dose 1
Healthcare visit (other): Neurologist
Release 6 — day 14, dose 1
Symptoms: Light headed
Release 11 — 6 months, dose 3
Symptoms: Ectopic pregnancy
Release 12 — 12 months, dose 3
Symptoms: Ectopic pregnancy, sinus infection, cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Ectopic pregnancy | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release